Paul Tudor Jones Danaher Corp Put Options Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$239.25 - $280.76 $1.65 Million - $1.94 Million	6,900 New	6,900 $1.92 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $240,630 - $303,069	1,300 Added 6.02%	22,900 $5.3 Million
Q3 2023 Nov 15, 2023	SELL	$233.08 - $265.59 $675,932 - $770,210	-2,900 Reduced 11.84%	21,600 $5.36 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $5.22 Million - $5.94 Million	23,200 Added 1784.62%	24,500 $5.88 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $311,675 - $360,100	1,300 New	1,300 $328,000
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $321,178 - $1.96 Million	1,300 New	1,300 $335,000
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $360,178 - $442,064	-1,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $408,912 - $460,614	1,400 New	1,400 $461,000

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.